The 1 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 95.00, with a high estimate of 95.00 and a low estimate of 95.00. The median estimate represents a +0.76% increase from the last price of 94.28.
The current consensus among 1 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.61
Reporting Date Jul 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.